Evidence map›Paper›PMID 27347352›Full record

ArticleAmerican journal of translational research2016

Exosome-mediated transfer from the tumor microenvironment increases TGFβ signaling in squamous cell carcinoma.

Lucia R Languino, Amrita Singh, Marco Prisco, Gareth J Inman, Adam Luginbuhl, Joseph M Curry, Andrew P South

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Hitting the target: cell signaling pathways modulation by extracellular vesicles.Extracellular vesicles and circulating nucleic acids · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lucia R LanguinoDepartment of Cancer Biology, Thomas Jefferson University Philadelphia, USA.
Amrita SinghDepartment of Cancer Biology, Thomas Jefferson University Philadelphia, USA.
Marco PriscoDepartment of Dermatology & Cutaneous Biology, Thomas Jefferson University Philadelphia, USA.
Gareth J InmanDivision of Cancer Research, School of Medicine, University of Dundee UK.
Adam LuginbuhlDepartment of Otolaryngology Head and Neck Surgery, Thomas Jefferson UniversityPhiladelphia, USA; Squamous Cell Carcinoma Tumor Ecology and Microenvironment (STEM) Research Group, Thomas Jefferson UniversityPhiladelphia, USA.
Joseph M CurryDepartment of Otolaryngology Head and Neck Surgery, Thomas Jefferson UniversityPhiladelphia, USA; Squamous Cell Carcinoma Tumor Ecology and Microenvironment (STEM) Research Group, Thomas Jefferson UniversityPhiladelphia, USA.
Andrew P SouthDepartment of Dermatology & Cutaneous Biology, Thomas Jefferson UniversityPhiladelphia, USA; Squamous Cell Carcinoma Tumor Ecology and Microenvironment (STEM) Research Group, Thomas Jefferson UniversityPhiladelphia, USA.
Thomas Jefferson University · US

Funding

Role of Runx2 in prostate tumorigenesis and metastasisP01CA140043 · NCI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2010 to 2021
$12.2M
INTEGRIN SIGNALING PATHWAYS IN PROSTATE CANCERR01CA089720 · NCI · YALE UNIVERSITY · PI LANGUINO, LUCIA R. · 2001 to 2014
$2.8M
NCI NIH HHS P01 CA140043NCI NIH HHS R01 CA089720
6 · The paper itself

Abstract

Transforming growth factor-beta (TGFβ) signaling in cancer is context dependent and acts either as a tumor suppressor or a tumor promoter. Loss of function mutation in TGFβ type II receptor (TβRII) is a frequent event in oral cavity squamous cell carcinoma (SCC). Recently, heterogeneity of TGFβ response has been described at the leading edge of SCC and this heterogeneity has been shown to influence stem cell renewal and drug resistance. Because exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways we investigated whether exosomes contain components of the TGFβ signaling pathway and whether exosome transfer between stromal fibroblasts and tumor cells can influence TGFβ signaling in SCC. We demonstrate that exosomes purified from stromal fibroblasts isolated from patients with oral SCC contains TβRII. We also demonstrate that transfer of fibroblast exosomes increases TGFβ signaling in SCC keratinocytes devoid of TβRII which remain non-responsive to TGFβ ligand in the absence of exosome transfer. Overall our data show that stromal communication with tumor cells can direct TGFβ signaling in SCC.

Indexed as

Exosomessquamous cell carcinomatransforming growth factor-betatumor microenvironment

Identifiers

PMID27347352
PMCPMC4891457
OpenAlexW2464515216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.